Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit

Completed · Not applicable · Has a placebo group

Conditions studied: Tobacco Use Disorder

In brief

The investigators will randomize smokers to receive 1) Varenicline + smoking cessation/reduction counseling or 2) Placebo pill + smoking cessation/reduction counseling. Neither the participants nor the research therapists/evaluators will know to which condition (active or placebo pill) the participants have been assigned i.e., a double-blind study). The medication and weekly counseling will occur for 28 days. Participants will complete assessment measures just before the start of treatment (baseline), at the end-of-treatment, at 1-month, 3-month, and at 6-months to determine if there are differences in tobacco use between treatment groups.

Key facts

Study ID
NCT01308736
Run by
Rutgers, The State University of New Jersey
People needed
73
Starts
2011-01-01
Expected to finish
2014-02-01
Last updated by the study team
2017-07-17

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.